Cargando…
A stress-free strategy to correct point mutations in patient iPS cells
When studying patient specific induced pluripotent stem cells (iPS cells) as a disease model, the ideal control is an isogenic line that has corrected the point mutation, instead of iPS cells from siblings or other healthy subjects. However, repairing a point mutation in iPS cells even with the newl...
Autores principales: | Cai, Jingli, Kropf, Elizabeth, Hou, Ya-Ming, Iacovitti, Lorraine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283763/ https://www.ncbi.nlm.nih.gov/pubmed/33857832 http://dx.doi.org/10.1016/j.scr.2021.102332 |
Ejemplares similares
-
Beyond iPS!
Publicado: (2012) -
Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson’s disease
por: Kostuk, Eric Wildon, et al.
Publicado: (2018) -
Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
por: Wang, Heuy-Ching, et al.
Publicado: (2014) -
Tumor-free iPS stem cells for heart cells
por: Phillips, M Ian
Publicado: (2014) -
What is the point of large-scale collections of human iPS cells?
por: Mckernan, Ruth, et al.
Publicado: (2013)